Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Pozycja w akcjach #47
Merck & Co., Inc. operates as a healthcare company worldwide. It operates... Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Cena akcji
$115.67
Kapitalizacja rynkowa
$285.98B
Zmiana (1 dzień)
1.30%
Zmiana (1 rok)
25.31%
Kraj
US
Handel Merck & Co., Inc. (MRK)

Kategoria

Zyski dla Merck & Co., Inc. (MRK)
Zyski w Dec 2025 TTM: $21.07B
Według najnowszych raportów finansowych Merck & Co., Inc., obecny zysk firmy wynosi $21.07B. W roku 2024 firma osiągnęła zysk w wysokości $19.94B, wzrost w porównaniu do zysku z roku 2023, który wynosił $1.89B. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Merck & Co., Inc. od 2000 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $21.07B 0.00%
2025 $21.07B 5.67%
2024 $19.94B 955.37%
2023 $1.89B -88.51%
2022 $16.44B 18.48%
2021 $13.88B 136.72%
2020 $5.86B -18.24%
2019 $7.17B -17.58%
2018 $8.70B 33.43%
2017 $6.52B 39.97%
2016 $4.66B -13.74%
2015 $5.40B -68.75%
2014 $17.28B 211.69%
2013 $5.55B -36.55%
2012 $8.74B 19.16%
2011 $7.33B 343.68%
2010 $1.65B -89.19%
2009 $15.29B 53.96%
2008 $9.93B 194.63%
2007 $3.37B -45.82%
2006 $6.22B -15.51%
2005 $7.36B -7.98%
2004 $8.00B -11.59%
2003 $9.05B -6.22%
2002 $9.65B -2.98%
2001 $9.95B 1.26%
2000 $9.82B 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$25.73B 22.13%
US
$12.40B -41.13%
GB
$32.58B 54.65%
US
$6.60B -68.69%
US
$16.35B -22.38%
CH